Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.690
0.00 (0.00%)
Feb 18, 2026, 12:43 PM EST - Market open
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $159.81 million as of February 18, 2026. Its market cap has decreased by -5.83% in one year.
Market Cap
159.81M
Enterprise Value
120.78M
1-Year Change
-5.83%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $159.81M, an increase of 27.62%. That is a compound annual growth rate of 1.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 159.81M | -7.83% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 169.86M |
| Sagimet Biosciences | 167.49M |
| Eledon Pharmaceuticals | 167.43M |
| Connect Biopharma Holdings | 158.77M |
| Compugen | 157.14M |
| Rani Therapeutics Holdings | 155.55M |
| Adagene | 155.06M |
| Kalaris Therapeutics | 154.58M |